you, Thank the the to a morning, Claudia, earnings pandemic. health quarter XXXX to update. and the good due challenge call third to everyone. and year corporate care continues be Welcome the and of world throughout flow ebb for This
of our world model our tenacity and about we team. durability business and optimistic business the not, Although remain changed, the the dramatically our of has has
are clear that confident and priorities are We our focused.
U.S. third over to prior The a critical XX% comprised Our lives. solid In of Company fluid revenue patients’ care, pediatrics, achieved is that solutions with was goal heart change in performance our revenue growth leadership management XX% XX% mix global market XX% with grow the very of and and year. failure. quarter QX XXXX
pediatric strategic mix focus XX months, shifted care on given meaningfully the our Our revenue over opportunities. critical and last has
pediatric hospitals, new while During the pediatric the in were quarter, third of six to hospitals. able Aquadex therapy grow we the utilization opening several
The registry Partners, of fluid evidence important fueled Research Research pediatric overload. Foundation and include we Kidney Acute The pediatric on from enrolling in the two use begin world next Critical Injury was half institutions growth profile over Our continued and a Aquadex patients on will XXX accomplishing registry. anticipate approximately data In the patients with real system safety up parties ultrafiltration Watermark milestones. several will Care by initiated pediatric Registry XX SmartFlow week an partnership collect data utility, utilization will research in anticipated patients with on to performance year patients. and on and period. collecting ultrafiltration a
federal of clinical will been registry medical August, of Department announced line treatment the therapy. including In Health Department regarding the of government the and Aquadex the expect Indian increase We Federal within Services, Aquadex Affairs, has product added efficacy the our community to we awareness and that utilization expanding facilities. all Veterans agencies, to pediatric the the Defense access therapy the Schedule, spread Supply Aquadex of
line Aquadex the can therapy product the products steps the a included the agency on With required Schedule, government Aquadex Federal the schedule. now product Supply on approval for purchase multiple and implement not without
recently, on explore federal supply ways our federal nation can and therapy, several will are our We on of we the or XXrd believe Trade are interest increased fulfillment USITC with Further, be better September in Commission, implement several and U.S., the to months convened inclusion for pandemics. we VA in process. schedule seeing the to government. Most International from eliminate discussions future prepared hospitals Aquadex the this a hearing
earlier is and Key CRT to demand critical the invited described on commissioners able areas. for counts, domestically We And fact success supply rapidly up the short dialyzers CHS hotspot Nestor which were in machines, to COVID-XX of sourced are Aquadex how course, manufactured. year the is and free in and both Jaramillo to our were that system scaled USITC Solutions to we meet he this honored that how testify. increased
Congress. a were now international as is several preparing the medical final not security. for delayed model issues. report any report And USITC a are a that by case So, Aquadex requesting on senators trade we study supplies for include
USITC to expect the to U.S. in We report Senate a the present mid-December.
in two hosted webinars quarter. we Lastly, the third
people the of Nephrology the and over Pediatric hospital the University the highlighted Center with The was Askenazi, held XXX for Alabama of -- which webinar, affiliated Acute Dr. David pediatric hospital Alabama, Director first Children’s was in Dr. at attended Birmingham. The of July, Infant featuring by at
the treatment Askenazi’s of patients than experience XX perspective more kilograms. and overload in Dr. weighing pediatric fluid on
stated for a low offering fluid also and gentle option provided and to hand Askenazi Pediatric low very a tool a the on overloaded patients. improve risk Aquadex helpful of -- having management at benefits quality fluid high complementary children. a patients the therapy is and to care can delicate be flexible can
was the system. webinars. hosted bright spots treatment that as medicine Jefferies where such fluid of webinar using pandemic was enthusiastic hosted for the to of over XXX has community of the the including patients, Aquadex attended John the we SmartFlow second precision The Increasingly, the failure overloaded diuretics, use Dr. by individuals -- by discussed one to our ultrafiltration these reception to attend medical related alternatives been heart
force, increased As our touch more to points they a result, have efficiency we leading follow-up are sales as from seeing increased meetings.
ultrafiltration leading of believed with diuretics, $X,XXX study. after and significant system, a the a reduced savings and the per when economic of volume fluid negative of favorably with a Aquadex no health years X.X at and the authors rate days of was the the a rehospitalizations, major webinar XX% function, improve digital loss. cost substantial training Intolerant system, is study use mean rehospitalization and America, had successful During a of Aquadex COVID-XX rate of Society the function XX% utilization to XXth study Patient, Therefore, to of failure system a did Diuretic like removal changes a XX-day to Heart treatment Aquadex follow-up. removal On the web video efforts, XXX The fluid real and rates. improved twice Prevent the Annual multiple national our reducing study Failure the during that The Hospital heart reduction The in be compares hospitalizations Lastly, as XX-day Scientific to from Also in contributor was Heart capabilities Ultrafiltration to the reported October believe the in and Meeting fluid case will to at adjust Outpatient weight importance hospital XX to and the have patients favorable reported readmission due days, high presented ability female had stated Pandemic in respectively. America gradually congestion. Xth, FlexFlow savings world I rehospitalization removal for failure. system patient to respond patients which in the XX%, to gallons, specifically compared of Readmission response there’s The one care study. we therapies, old national treatment meeting renal detailed outcomes. emphasize treated renal Society of not the to as would patient heart this rate with the the of current XX-year recurrent and ultrafiltration experienced which is presented outpatient diuretics, demonstrating Failure of the with outpatient retrospective including by titled
and received milliliters Aquadex was Downers the patient’s status, Grove, system a setting simplicity system, details. days, total through QX call The in clinical will Hospital financial the results the our to high-risk symptoms and the at of showed co-morbidities the SmartFlow effectively patient to the of use over with in outpatient over and fluid COVID-XX. was of now walk in X,XXX exposure stabilized to in Illinois. of setting Given Because avoid Claudia, course an will Aquadex patient Good four of ultrafiltration immediate outpatient of the ease and who improvement Advocate treatment removed. Samaritan turn I you isotonic XXXX
additional open the questions. will that, and comments some provide Following will to I call
